Resources

Correlation of capillary serum was demonstrated for professionally collected TAP II samples, self-collected TAP II samples, and professionally collected fingerstick samples.

TAP sample collection in decentralized drive-through settings enabled a comprehensive evaluation of Sars-CoV-2 antibody level and decay using WHO standards in a representative population of LA county during the pandemic.

TAP devices used to collect blood samples from 2-month-old and 6-month-old infants in Sars-CoV-2 infection risk study.

Use of TAP Point of Care Blood Collection Device for High-Quality Germline Whole Exome Sequencing on Illumina NGS Platforms with the Twist Bioscience Human Core WES Kit

Use of TAP Point of Care Blood Collection Device for Targeted Proteomics with the Olink Target 96 Cardiovascular II Panel Using Proximity Extension Assay Technology.

Use of the TAP Point of Care Blood Collection Device for Biomarker Assessments on the Quanterix Simoa HD-X Platform: Initial Feasibility for Plasma Biomarkers in Alzheimer’s Disease Detection.

Decentralized clinical trials represent a medical research paradigm shift, enhancing patient accessibility and engagement. The future holds increased patient-focused trials driven by regulatory and technological advancements, enabling frequent, less invasive data capture.

TAP® II devices, involves collecting a small blood samples that improves the patient experience, because it’s easier to use than other self-sampling devices.